verapamil has been researched along with Thyrotoxicosis in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aim of this study was to investigate antiarrhythmic and toxic effects of verapamil in mice and rats with thyrotoxicosis and hypothyroidism." | 7.74 | [Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats]. ( Afanas'eva, EIu; Arzamastsev, EV; Sokhanenkov, MIu; Sokhanenkova, AE, 2008) |
| "Aim of this study was to investigate antiarrhythmic and toxic effects of verapamil in mice and rats with thyrotoxicosis and hypothyroidism." | 3.74 | [Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats]. ( Afanas'eva, EIu; Arzamastsev, EV; Sokhanenkov, MIu; Sokhanenkova, AE, 2008) |
| "Verapamil treatment of the aortic constricted hearts prevented the rise in intracellular calcium, and attenuated phosphomonoester sugar accumulation." | 1.28 | Calcium inhibition of glycolysis contributes to ischaemic injury. ( Auffermann, W; Buser, P; Parmley, WW; Wagner, S; Wikman-Coffelt, J; Wu, S, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sokhanenkova, AE | 1 |
| Sokhanenkov, MIu | 1 |
| Afanas'eva, EIu | 1 |
| Arzamastsev, EV | 1 |
| Auffermann, W | 1 |
| Wagner, S | 1 |
| Wu, S | 1 |
| Buser, P | 1 |
| Parmley, WW | 1 |
| Wikman-Coffelt, J | 1 |
| Dahlstrøm, CG | 1 |
| Ladefoged, SD | 1 |
3 other studies available for verapamil and Thyrotoxicosis
| Article | Year |
|---|---|
[Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dose-Response Relatio | 2008 |
Calcium inhibition of glycolysis contributes to ischaemic injury.
Topics: Animals; Calcium; Coronary Disease; Glycolysis; Hypertension; In Vitro Techniques; Myocardial Reperf | 1990 |
[Verapamil in the treatment of atrial fibrillation in patients with thyrotoxicosis].
Topics: Aged; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Thyrotoxicosis; Verapamil | 1988 |